NCT05302609 - Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 4, 2022

Primary Completion Date

February 21, 2024

Study Completion Date

February 21, 2024

Conditions

Scleral Thinning

Interventions

BIOLOGICAL

SclerFIX

Chemically-treated, viro-inactivated, freeze-dried and irradiated umbilical cord lining membrane allograft used as substitute for scleral graft in reinforcement of scleral thinning.

Trial Locations (2)

69004

Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon

06000

Hôpital Pasteur 2 - CHU de NICE, Nice